Press releases
-
ICON recognised for leadership position in clinical research industry and as socially responsible employer
At the CRO Leadership Awards 2024, ICON was recognised for its excellence in clinical research in all categories.
-
ICON plc schedules second quarter 2024 earnings conference call
A conference call and webcast to discuss its financial results and performance on July 25, 2024.
-
ICON plc to present at the Jefferies Global Healthcare conference
ICON plc today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 1:30pm ET.
-
ICON hosts investor day and updates full year 2024 financial guidance
ICON plc will host its 2024 Investor Day today in New York City.
-
ICON plc to hold Investor Day meeting on May 30, 2024
This press release contains forward-looking statements, including statements about our financial guidance.
-
ICON releases its ICON Cares 2023 Report
This outlines how the company is delivering on its ESG, diversity, inclusion and belonging, and CSR goals, as delivered through its ICON Cares program.
-
ICON announces pricing of USD 2 billion notes
Consisting of $750,000,000 5.809% Senior Secured Notes due 2027, $750,000,000 5.849% Senior Secured Notes due 2029 and $500,000,000 6.000% Senior Secured Notes due 2034 (collectively, the “Notes”).
-
ICON reports first quarter 2024 results
Quarter one revenue of $2,090.4 million representing an increase of 5.7% on prior year revenue and 5.4% on a constant currency basis.
-
ICON announces CFO transition
ICON today announced that Chief Financial Officer, Brendan Brennan, will leave his role at ICON in quarter four this year for a new opportunity outside of the CRO industry.
-
ICON plc schedules first quarter 2024 earnings conference call
Will hold a conference call and webcast to discuss its financial results and performance on 25 April, 2024.
